Synthesis of an HMG-CoA reductase inhibitor; a diastereoselective aldol approach
β Scribed by J.E Lynch; R.P Volante; R.V Wattley; I Shinkai
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- French
- Weight
- 176 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
β¦ Synopsis
The synthesis of the B-hydroxy-6 -1actone moiety of an HMG-CoA reductase inhibitor in its correct absolute configuration (94% ee) has been accomplished via a diastereoselective aldol reaction enolate of S(+)1,2,2-triphenylethylacetate, between aldehyde 4 and the magnesium Claisen condensation, directed reduction of the resulting 6-hydroxy-B-keto ester. and hydroxyl
π SIMILAR VOLUMES
The synthesis of a new 3-hydroxy-3-methylglutaryl coenzyme A reduc-----tase inhibitor starting from 4,4' -difluorobenzophenone is described. Mevinolin 1 and its congeners are potent inhibitors of 3-hydroxy-3-methyl-
Abstmet: Upon exposure to intense simulated sunlight, CI-981 (1) readily decomposes into three major by-products. This paper reports on the products formed when I is decomposed in acetommlelwater solutions under intense simulated sunlight, ult~~~olet b&t filtered at 254 mn and visible light, In&ded
The synthesis of a new fluoro-substituted 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor 2 in high optical purity via addition of the chiral enolate 12 to fluoro aldehyde 82 is described.
## Abstract A new synthetic method for the preparation of pitavastatin is described. The approach circumvents various synthetic problems associated with the buildup of the 3,5βdihydroxyβC~7~ acid side chain of HMGβCoA reductase inhibitors (statins). The use of the C~6~βamide derivative **5** instea
On p. 1074, in Scheme 3, the correct formula of NK-104 should be as follows: 2) On p. 1077, line 16 should read as follows: (390 ml) was cooled to Γ 788, and 1.6m BuLi in hexane (374.4 g, 881 mmol) was added under 3) On p. 1078, line 15 should read as follows: As HPLC revealed the presence of mor